chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: M
Vaccine: ANTH, FLUX, SMALL, ANTH, FLUX, SMALL
Symptoms: Chest pain, Dyspnoea, Electrocardiogram PR interval, Electrocardiogram ST segment elevation
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 441058. A 21-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000, lot number VV04-003-A, Influenza Vaccine (seasonal, lot number unknown), and anthrax vaccine (other manufacturer, lot number not reported) and approximately 15 days later, on 15 June 2011, the patient developed chest pain and shortness of breath (SOB). Laboratory data revealed EKG with ST elevation and PR depression. The patient recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, FLUX, SMALL, ANTH, FLUX, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Myocarditis, Pericardial disease, Pericarditis
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 441058. A 21-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000, lot number VV04-003-A, Influenza Vaccine (seasonal, lot number unknown), and anthrax vaccine (other manufacturer, lot number not reported) and approximately 15 days later, on 15 June 2011, the patient developed chest pain and shortness of breath (SOB). Laboratory data revealed EKG with ST elevation and PR depression. The patient recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, FLUX, SMALL, ANTH, FLUX, SMALL
Symptoms: Troponin I increased
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 441058. A 21-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000, lot number VV04-003-A, Influenza Vaccine (seasonal, lot number unknown), and anthrax vaccine (other manufacturer, lot number not reported) and approximately 15 days later, on 15 June 2011, the patient developed chest pain and shortness of breath (SOB). Laboratory data revealed EKG with ST elevation and PR depression. The patient recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, FLUX, SMALL, ANTH, FLUX, SMALL
Symptoms: Chest pain, Dyspnoea, Electrocardiogram PR interval, Electrocardiogram ST segment elevation
Clinical narrative: This study case was received from the investigator in the trial on 28 October 2011. A 21 year-old male subject with no significant medical history was found to have an unspecified disease of the pericardium, a non-specific myocarditis and an acute pericarditis, unspecified 15, 22 and 22 days respectively after he had received an injection of ACAM2000 (lot number, route and site of administration not reported), an injection of anthrax 1 (manufacturer, lot number, route and site of administration not reported) and an influenza split virus vaccine (manufacturer, lot number, route and site of administration not reported) on 31 May 2011. Relevant laboratory data on 15 June 2011 included: an abnormal Troponin I (highest recorded value not reported), an abnormal ECG and an abnormal Echocardiogram. Lumbar puncture and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: ANTH, FLUX, SMALL, ANTH, FLUX, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Myocarditis, Pericardial disease, Pericarditis
Clinical narrative: This study case was received from the investigator in the trial on 28 October 2011. A 21 year-old male subject with no significant medical history was found to have an unspecified disease of the pericardium, a non-specific myocarditis and an acute pericarditis, unspecified 15, 22 and 22 days respectively after he had received an injection of ACAM2000 (lot number, route and site of administration not reported), an injection of anthrax 1 (manufacturer, lot number, route and site of administration not reported) and an influenza split virus vaccine (manufacturer, lot number, route and site of administration not reported) on 31 May 2011. Relevant laboratory data on 15 June 2011 included: an abnormal Troponin I (highest recorded value not reported), an abnormal ECG and an abnormal Echocardiogram. Lumbar puncture and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: ANTH, FLUX, SMALL, ANTH, FLUX, SMALL
Symptoms: Troponin I increased
Clinical narrative: This study case was received from the investigator in the trial on 28 October 2011. A 21 year-old male subject with no significant medical history was found to have an unspecified disease of the pericardium, a non-specific myocarditis and an acute pericarditis, unspecified 15, 22 and 22 days respectively after he had received an injection of ACAM2000 (lot number, route and site of administration not reported), an injection of anthrax 1 (manufacturer, lot number, route and site of administration not reported) and an influenza split virus vaccine (manufacturer, lot number, route and site of administration not reported) on 31 May 2011. Relevant laboratory data on 15 June 2011 included: an abnormal Troponin I (highest recorded value not reported), an abnormal ECG and an abnormal Echocardiogram. Lumbar puncture and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Chest pain, Dyspnoea, Electrocardiogram ST segment elevation
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 441090. A 22-year-old male patient received the following vaccinations on 28 September 2010: ACAM2000 (SP Biologics Co. lot number VV04003A) and AFLURIA (CSL Limited lot number M51507). It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration and no prior medical history. It was not reported if the patient had any prior vaccinations. On 08 October 2010, the patient had chest pain that was worse when lying down and eased when sitting up and it was difficult to take a deep breath. The patient also had increased blood creatine phosphokinase MB and blood creatine phosphokinase, fatigue, malaise and pyrexia. The patient did not present to the emergency room (ER) until 09 October 2011. The patient was hospitalized (dates not reported). The patient's laboratory data included troponin 0.63, CK 2169 and CK-MB 2.44. The patient also had an electrocardiogram (EKG) with ST elevation. No further information was available at the time of the report. The outcome was reported as recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL
Symptoms: Fatigue, Malaise, Pyrexia, Troponin increased
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 441090. A 22-year-old male patient received the following vaccinations on 28 September 2010: ACAM2000 (SP Biologics Co. lot number VV04003A) and AFLURIA (CSL Limited lot number M51507). It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration and no prior medical history. It was not reported if the patient had any prior vaccinations. On 08 October 2010, the patient had chest pain that was worse when lying down and eased when sitting up and it was difficult to take a deep breath. The patient also had increased blood creatine phosphokinase MB and blood creatine phosphokinase, fatigue, malaise and pyrexia. The patient did not present to the emergency room (ER) until 09 October 2011. The patient was hospitalized (dates not reported). The patient's laboratory data included troponin 0.63, CK 2169 and CK-MB 2.44. The patient also had an electrocardiogram (EKG) with ST elevation. No further information was available at the time of the report. The outcome was reported as recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. Documents held by sender: None.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain, Injected limb mobility decreased, Injection site pain, Myalgia
Clinical narrative: Case received on 18 October 2011 from a healthcare professional and from a consumer. A 53-year-old female patient, with no known allergies and no illness at time of vaccination, had received on 12 October 2011 her intramuscular dose of FLUZONE (batch number UH475AA, number in series unknown) on her deltoid. The injection was given high at the deltoid. The patient had received a concomitant therapy with ZOLOFT, chlorazepate and Synthroid. On 12 October 2011, i.e. the day of immunization, the patient complained of extended muscle aching going to the shoulder down arm to some fingers. She went to her doctor who put her on muscle relaxants. On 13 October 2011, the patient developed pain at the injection site. It radiated to her shoulder, back, neck, ear down her arm to her hand. She could barely lift her arm. The pain was severe. She felt like arthritis when she first went up to the "AM". Muscle relaxants did not help. At the time of reporting, the patient had not recovered. Follow-up report was received from a healthcare professional on 10 January 2012. It was reported no word from the patient; however if the symptoms still persist; only that she had them for two weeks after administration. On 18 October 2011 after going to the doctor, the patient was given TRAMADOL 50mg 1 tablet 2 x daily # 20 (10 days supply), orphenadrine extended release (ER) 100mg 1 tablet 2 x daily #30 (15 days supply) and prednisone 5mg tablets take u.d. #48 (12 days supply). On 10 November 2011, she was also given gabapentin 300mg 1 capsule at bedtime #30. On 29 November 2011, the gabapentin was increased to 300mg 1 capsule 3 x daily # 90 (30 days supply). It is unknown if a diagnosis or tests/lab data was performed. The patient outcome was reported as unknown. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Arthropathy, Blood culture, Blood folate normal, Blood thyroid stimulating hormone normal, CSF culture
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: CSF lymphocyte count increased, CSF white blood cell count increased, Clonus, Cytomegalovirus test, Enterovirus test
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Extensor plantar response, Full blood count normal, HIV test, Headache, Herpes simplex serology
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Hyperreflexia, Laboratory test normal, Metabolic function test normal, Muscular weakness, Nausea
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Nuclear magnetic resonance imaging brain normal, Nuclear magnetic resonance imaging spinal cord normal, Polymerase chain reaction, Viral test negative, Vitamin B12 normal
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Vomiting
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Axillary mass, Chest discomfort, Encephalitis, Encephalomyelitis, Headache
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, HEPAB, JEV, SMALL, TYP
Symptoms: Nausea, Photophobia, Vomiting
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442421. A 20-year-old male patient received an injection of ACAM2000 (SP Biologics Co. lot number not reported) on 31 October 2011. It was not reported if the patient was on any other medications at the time of smallpox vaccine administration. The patient had no current illnesses at the time of vaccine administration. The patient had a medical history of temporomandibular joint (TMJ). It was not reported if the patient had any prior vaccinations. On 13 November 2011, the patient experienced life threatening symptoms of "one day of upper motor neuron findings including hyperreflexia with clonus and 2-3 joint involvement, +Babinski with 2 joint involvement, lower>upper limb weakness, severe headache (HA), nausea and vomiting. The concern was for postvaccina encephalomyelitis. The symptoms were largely resolving on HD 2 with supportive care, without IVIG or corticosteroids". The patient was hospitalized (datesnot reported). The patient's laboratory data included cerebrospinal fluid (CSF): 303 white blood cells (WBC), 70% lymphs, vaccinia (polymerase chain reaction) PCR negative, thyroid stimulating hormone (TSH), vitamin B12, blood folate, basic metabolic panel (BMP) and complete blood count (CBC) were all normal. Cytomegalovirus (CMV), human immunodeficiency virus (HIV), enterovirus (EV), West Nile virus (WNV), herpes simplex virus (HSV), CSF culture and blood cultures were all pending. The patient's magnetic resonance imaging (MRI) of the brain/spine was without lesion or evidence of demyelination. No further information was available at the time of the report. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, FLUN3, SMALL
Symptoms: Chest pain, Headache, Lymphadenitis, Musculoskeletal pain, Nausea
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442570. A 20-year-old male patient received the following vaccinations on 18 October 2011: ACAM2000 (SP Biologics Co. lot number VV04003A), BIOTHRAX (Emergent lot number FAV292) and FLUMIST (Medimmune lot number 501096P). The patient had no current illness at the time of vaccine administration. The patient had no reported medical history. It was unknown if the patient had any prior vaccinations. The patient also had a PPD test. On 20 October 2011, the patient had pain in the left arm radiating to the shoulder and chest for five days, lymphadenitis, headache and nausea/vomiting for three weeks. The patient was seen in neurology on ZOMIG 20mg, ELAVIL, FIORICET, MIGRANOL. The patient had an MRI (no results reported). No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, FLUN3, SMALL
Symptoms: Nuclear magnetic resonance imaging, Pain in extremity, Vomiting
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442570. A 20-year-old male patient received the following vaccinations on 18 October 2011: ACAM2000 (SP Biologics Co. lot number VV04003A), BIOTHRAX (Emergent lot number FAV292) and FLUMIST (Medimmune lot number 501096P). The patient had no current illness at the time of vaccine administration. The patient had no reported medical history. It was unknown if the patient had any prior vaccinations. The patient also had a PPD test. On 20 October 2011, the patient had pain in the left arm radiating to the shoulder and chest for five days, lymphadenitis, headache and nausea/vomiting for three weeks. The patient was seen in neurology on ZOMIG 20mg, ELAVIL, FIORICET, MIGRANOL. The patient had an MRI (no results reported). No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: ANTH, FLUN3, SMALL
Symptoms: Human chorionic gonadotropin negative, Secondary transmission
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442589. A 19-year-old female patient is the spouse of a person who reportedly was given an intradermal administration (site unknown) of ACAM2000 (lot number VV04-003-A), BIOTHRAX (Emergent, lot number FAV294, route and site of administration unknown), and intranasal FLUMIST (Medimmune, lot number 501094P) on 26 October 2011. 12 days post-vaccination, the patient developed a similar sore to that of her husband. She stated that he did keep it clean and covered as instructed, but they share bed sheets, towels, etc. The patient had a "typical major reaction" to the ACAM2000 on her right forearm. There were no concomitant medications and no concomitant illnesses. The serum human chorionic gonadotropin (HCG) test was negative. The recovery was unknown at the time of reporting. Documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: SMALL
Symptoms: Cellulitis, Dyspnoea, Full blood count, Metabolic function test
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442779. A 36-year-old male patient with no concurrent illnesses or medical history received the following vaccination on 04 November 2011: ACAM2000 (lot number not reported) and 5 days later had cellulitis of left arm that was spreading (coded by VAERS as injection site cellulitis), and shortness of breath (SOB) that required emergency visit. Laboratory data included complete blood count (CBC) and comprehensive metabolic panel (CMP) without reported results. The patient's recovery status was unknown. Documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: SMALL
Symptoms: Fatigue, Headache, Lymph node pain, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442793. A 41-year-old male patient received ACAM2000 (SP Biologics Co. lot number VV04-003-A) on 04 November 2011. The patient had an allergy to erythromycin. Current illness was reported as none. It was not reported if the patient took concomitant medications or had any prior vaccinations. On 12 November 2011, the patient experienced a headache, body aches, fatigue, nasal congestion, post nasal drip, enlarged/tender axillary and cervical lymph node, neck felt stiff and sore,  two scattered pustules on shoulder, one on back and one on left leg.  The outcome was reported as unknown. Documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: SMALL
Symptoms: Nasal congestion, Neck pain, Pain, Rash pustular, Upper-airway cough syndrome
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 442793. A 41-year-old male patient received ACAM2000 (SP Biologics Co. lot number VV04-003-A) on 04 November 2011. The patient had an allergy to erythromycin. Current illness was reported as none. It was not reported if the patient took concomitant medications or had any prior vaccinations. On 12 November 2011, the patient experienced a headache, body aches, fatigue, nasal congestion, post nasal drip, enlarged/tender axillary and cervical lymph node, neck felt stiff and sore,  two scattered pustules on shoulder, one on back and one on left leg.  The outcome was reported as unknown. Documents held by sender: None.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Adverse reaction
Clinical narrative: Follow-up information was received from a healthcare professional on 17 January 2012. On 17 November 2011, the patient required a doctor visit, and received corrective treatment with BENADRYL. It was suggested not getting the flu vaccine again. The patient outcome was reported as recovered/resolved on 26 November 2011. Documents held by sender: none.
Age: 26.0
Sex: F
Vaccine: ANTH, SMALL, TYP
Symptoms: Rash pruritic, Urticaria
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443469. A 26-year-old female patient received the following vaccinations on 28 October 2011: ACAM2000 (SP Biologics Co. lot  number VV04003A), TYPHIM VI (sanofi pasteur SA lot number G11241),  BIOTHRAX (Emergent, lot number FAV294). The patient also had IMPLANON implant placed on left axillary area the same day. Current illness and medical history were reported as none. It was not reported if the patient had any prior vaccinations. On 04 November 2011, the patient stated that an itchy rash started. The patient was seen on 07 November 2011 and diagnosed (dx) with "Urticaria Allergic Parenterally - Administered Agent". A wheal was seen as well as multiple irregular shaped erythemic shaped wheals. Lesions had high concentration on the left deltoid area (at smallpox inoculation site and same a tape borders) and in center of chest. The lesions started to become less further from those two locations and became few on distal extremities. The patient stated increased lesions where underwear made contact. There were moderate amount of lesions on the back and few lesions on the face. The lesions blanch with pressure, without drainage, warmth, tenderness, induration or vesicles. There were no lesions at the site of IMPLANON placement. The outcome was reported as unknown. Documents held by sender.
Age: 25.0
Sex: M
Vaccine: SMALL
Symptoms: Vaccination site infection
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443570. A 25-year-old male patient with no concurrent illnesses or medical history received the following vaccination on 18 October 2011: ACAM2000 (lot number VV04-003-A) and 6 days later had infection of the vaccination site. Other medications included Doxycycline, Omeprazole, and multi-vitamin. The patient recovered on an unspecified date. Documents held by sender: None.
Age: 39.0
Sex: M
Vaccine: SMALL
Symptoms: Oedema peripheral, Vaccination site infection
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443574. A 39-year-old male patient with no concurrent illnesses or medical history received the following vaccination on 12 October 2011: ACAM2000 (lot number VV04-003-A) and 4 days later had infection of the vaccination site with swelling of the arm that required emergency visit. Other medications: Doxycycline tab, KEFLEX, and BACTROBAN cream 2%. The patient recovered on an unspecified date. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Activated partial thromboplastin time prolonged, Blood creatine increased, Blood creatine phosphokinase increased, Blood fibrinogen decreased, Body temperature increased
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443712. An 18-year-old male patient with allergy to primaquine, and who was G6PD deficient had received the following vaccinations on 15 November 2011: ACAM2000 (lot number VV040003A), TYHPIM VI (lot number B1026), and BIOTHRAX (lot number FAV294) and eight days later, on 23 November 2011 the patient was on a 5 mile run and passed out. His heart rate was greater than 180 beats/minute and he had a temperature of 102.9 degrees Fahrenheit. He was administered adenosine and underwent cardioversion with intravenous fluids (IVF), and was admitted to the ICU and placed on broad spectrum antibiotics. An unspecified culture was drawn without reported results. The patient experienced progressive rhabdomyolysis, disseminated intravascular coagulation (DIC), renal failure, pain, and encephalopathy. He was treated with "cryo", fresh frozen plasma (FFP), fluids, pressors and ultimately transferred to another facility. Laboratory data revealed leukocytosis, thrombocytosis, decreased fibrinogen and prolonged prothrombin-time/partial thromboplastin time (PT/PPT), elevated liver enzymes, increased creatine, increased creatine kinase, transient elevated troponin I (TNIs). The patient had no other active medications except for Doxycycline taken prophylactically for malaria approximately 2 days prior. The patient died on an unspecified date. Follow-up information was received 13 March 2012. According to the reporter, they had no report in their files indicating the patient expired, and they were unable to provide any additional information at the time of the report. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Cardioversion, Culture, Death, Disseminated intravascular coagulation, Encephalopathy
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443712. An 18-year-old male patient with allergy to primaquine, and who was G6PD deficient had received the following vaccinations on 15 November 2011: ACAM2000 (lot number VV040003A), TYHPIM VI (lot number B1026), and BIOTHRAX (lot number FAV294) and eight days later, on 23 November 2011 the patient was on a 5 mile run and passed out. His heart rate was greater than 180 beats/minute and he had a temperature of 102.9 degrees Fahrenheit. He was administered adenosine and underwent cardioversion with intravenous fluids (IVF), and was admitted to the ICU and placed on broad spectrum antibiotics. An unspecified culture was drawn without reported results. The patient experienced progressive rhabdomyolysis, disseminated intravascular coagulation (DIC), renal failure, pain, and encephalopathy. He was treated with "cryo", fresh frozen plasma (FFP), fluids, pressors and ultimately transferred to another facility. Laboratory data revealed leukocytosis, thrombocytosis, decreased fibrinogen and prolonged prothrombin-time/partial thromboplastin time (PT/PPT), elevated liver enzymes, increased creatine, increased creatine kinase, transient elevated troponin I (TNIs). The patient had no other active medications except for Doxycycline taken prophylactically for malaria approximately 2 days prior. The patient died on an unspecified date. Follow-up information was received 13 March 2012. According to the reporter, they had no report in their files indicating the patient expired, and they were unable to provide any additional information at the time of the report. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Heart rate increased, Hepatic enzyme increased, Intensive care, Leukocytosis, Loss of consciousness
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443712. An 18-year-old male patient with allergy to primaquine, and who was G6PD deficient had received the following vaccinations on 15 November 2011: ACAM2000 (lot number VV040003A), TYHPIM VI (lot number B1026), and BIOTHRAX (lot number FAV294) and eight days later, on 23 November 2011 the patient was on a 5 mile run and passed out. His heart rate was greater than 180 beats/minute and he had a temperature of 102.9 degrees Fahrenheit. He was administered adenosine and underwent cardioversion with intravenous fluids (IVF), and was admitted to the ICU and placed on broad spectrum antibiotics. An unspecified culture was drawn without reported results. The patient experienced progressive rhabdomyolysis, disseminated intravascular coagulation (DIC), renal failure, pain, and encephalopathy. He was treated with "cryo", fresh frozen plasma (FFP), fluids, pressors and ultimately transferred to another facility. Laboratory data revealed leukocytosis, thrombocytosis, decreased fibrinogen and prolonged prothrombin-time/partial thromboplastin time (PT/PPT), elevated liver enzymes, increased creatine, increased creatine kinase, transient elevated troponin I (TNIs). The patient had no other active medications except for Doxycycline taken prophylactically for malaria approximately 2 days prior. The patient died on an unspecified date. Follow-up information was received 13 March 2012. According to the reporter, they had no report in their files indicating the patient expired, and they were unable to provide any additional information at the time of the report. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Pain, Prothrombin time prolonged, Renal failure, Rhabdomyolysis, Thrombocytosis
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443712. An 18-year-old male patient with allergy to primaquine, and who was G6PD deficient had received the following vaccinations on 15 November 2011: ACAM2000 (lot number VV040003A), TYHPIM VI (lot number B1026), and BIOTHRAX (lot number FAV294) and eight days later, on 23 November 2011 the patient was on a 5 mile run and passed out. His heart rate was greater than 180 beats/minute and he had a temperature of 102.9 degrees Fahrenheit. He was administered adenosine and underwent cardioversion with intravenous fluids (IVF), and was admitted to the ICU and placed on broad spectrum antibiotics. An unspecified culture was drawn without reported results. The patient experienced progressive rhabdomyolysis, disseminated intravascular coagulation (DIC), renal failure, pain, and encephalopathy. He was treated with "cryo", fresh frozen plasma (FFP), fluids, pressors and ultimately transferred to another facility. Laboratory data revealed leukocytosis, thrombocytosis, decreased fibrinogen and prolonged prothrombin-time/partial thromboplastin time (PT/PPT), elevated liver enzymes, increased creatine, increased creatine kinase, transient elevated troponin I (TNIs). The patient had no other active medications except for Doxycycline taken prophylactically for malaria approximately 2 days prior. The patient died on an unspecified date. Follow-up information was received 13 March 2012. According to the reporter, they had no report in their files indicating the patient expired, and they were unable to provide any additional information at the time of the report. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Troponin I increased
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443712. An 18-year-old male patient with allergy to primaquine, and who was G6PD deficient had received the following vaccinations on 15 November 2011: ACAM2000 (lot number VV040003A), TYHPIM VI (lot number B1026), and BIOTHRAX (lot number FAV294) and eight days later, on 23 November 2011 the patient was on a 5 mile run and passed out. His heart rate was greater than 180 beats/minute and he had a temperature of 102.9 degrees Fahrenheit. He was administered adenosine and underwent cardioversion with intravenous fluids (IVF), and was admitted to the ICU and placed on broad spectrum antibiotics. An unspecified culture was drawn without reported results. The patient experienced progressive rhabdomyolysis, disseminated intravascular coagulation (DIC), renal failure, pain, and encephalopathy. He was treated with "cryo", fresh frozen plasma (FFP), fluids, pressors and ultimately transferred to another facility. Laboratory data revealed leukocytosis, thrombocytosis, decreased fibrinogen and prolonged prothrombin-time/partial thromboplastin time (PT/PPT), elevated liver enzymes, increased creatine, increased creatine kinase, transient elevated troponin I (TNIs). The patient had no other active medications except for Doxycycline taken prophylactically for malaria approximately 2 days prior. The patient died on an unspecified date. Follow-up information was received 13 March 2012. According to the reporter, they had no report in their files indicating the patient expired, and they were unable to provide any additional information at the time of the report. Documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: SMALL
Symptoms: Vaccination site infection
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443828. A 36-year-old male patient with no concurrent illnesses, received the following vaccination on 27 August 2011: ACAM2000 (lot number VV04-003-A) and 3 days later had infection of the vaccination site requiring emergency visit. Other medications included "Rocephen", MOTRIN, and FLEXERIL. The patient recovered on an unspecified date. Documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: SMALL
Symptoms: Vaccination site infection
Clinical narrative: This case was received on 23 January 2012 via a third party query tool search on the VAERS database, under reference number 443838. A 36-year-old male patient with no concurrent illnesses or medical history received the following vaccination on 28 September 2011: ACAM2000 (lot number VV04-003-A) and 6 days later had infection of the vaccination site requiring emergency visit. Other medications included Doxycycline and NEXIUM. The patient recovered on an unspecified date. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: No adverse event, Wrong technique in drug usage process
Clinical narrative: This case was received on 06 March 2012 via a third party query tool search on the VAERS database under reference number 444158 which involves a case of misuse. A 19 year-old male patient had received the following vaccinations on 01 December 2011: a left arm injection of ACAM2000 (lot number VV04003A), an intramuscular left arm injection of TYPHIM VI (lot number E05491) and an intramuscular right arm injection of BIOTHRAX (lot number FAV297). According to the report, it was discovered after the patient was given the small pox vaccine it had been diluted with one milliliter (ml) more than it was suppose to have been. The patient was "watched" for 15 minutes. No adverse effects were reported. The patient was then asked to return in 10 days for further evaluation. The patient's outcome was reported as recovered. Documents held by sender: none.
Age: 30.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Activated partial thromboplastin time, Chest X-ray, Chills, Ecchymosis, Full blood count
Clinical narrative: This case was received on 06 March 2012 via a third party query tool search on the VAERS database, under reference number 444591. A 30-year-old male patient received the following vaccinations on 15 November 2011: a left arm ACAM2000 (lot number VV04003A) and a right arm intramuscular injection of anthrax (Emergent, lot number FAV294). The patient had no medical history, no current illnesses and other medications were reported as not applicable. The patient's previous vaccinations were not reported. The patient required an Emergency visit when he experienced fever, chills and pain at 8 of 10 in bilateral calves that lasted 1-2 hours then +3 pitting edema and ecchymosis of bilateral lower extremities set in. The patient was medevaced to the hospital and admitted for 2 days with the diagnosis of vasculitis. He had the following laboratory testing performed: chest x-ray, ultrasound of lower extremities, CBC, PT and PTT (results not provided). The patient was released on 29 November 2011 and was fit for full duty asymptomatic. The outcome was reported as recovered. Documents held by sender: None.